In:
Cancer, Wiley, Vol. 123, No. 2 ( 2017-01-15), p. 210-218
Abstract:
This study highlights the important role of partner and localizer of BRCA2 ( PALB2 ) in high‐risk, BRCA1/2 mutation–negative male breast cancer cases and indicates that male breast cancer may be helpful in the identification of PALB2 families. PALB2 seems now to be ready for clinical translation, and families with male breast cancer cases should be considered for PALB2 genetic testing with the aim of improving the clinical management of breast cancer patients and their relatives.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
Language:
English
Publisher:
Wiley
Publication Date:
2017
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1